Vir Biotechnology, Inc. SEC filings VIR
Vir Biotechnology, Inc. has 801 filings in SEC EDGAR's recent list, going back to Jun 29, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B5 | Prospectus supplement | Feb 26, 2026 | — |
| 424B5 | Prospectus supplement | Feb 24, 2026 | — |
| S-8 | Employee stock plan registration | Feb 23, 2026 | — |
| S-8 | Employee stock plan registration | Feb 27, 2025 | — |
| S-8 | Employee stock plan registration | Feb 26, 2024 | — |
| S-3ASR | Automatic shelf registration | Nov 3, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2023 | — |
| S-8 | Employee stock plan registration | Feb 28, 2022 | — |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| S-3ASR | Automatic shelf registration | Nov 10, 2020 | — |
| 424B4 | Prospectus | Jul 8, 2020 | — |
| S-1MEF | Filing | Jul 7, 2020 | — |
| S-1 | Registration statement | Jul 6, 2020 | — |
| S-8 | Employee stock plan registration | Mar 26, 2020 | — |
| S-8 | Employee stock plan registration | Oct 15, 2019 | — |
| 424B4 | Prospectus | Oct 11, 2019 | — |
| S-1/A | Amended registration statement | Sep 30, 2019 | — |
| S-1 | Registration statement | Sep 3, 2019 | — |
Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- VIR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Francisco, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1706431
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.